Phase Clinical Trial of mouth rinsing with MA-T107 in patients with periodontitis

Phase Clinical Trial of mouth rinsing with MA-T107 in patients with periodontitis - Effect of mouth rinsing with MA-T107 for Periodontitis

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009436

Enrollment

Registered

2012-11-29

Start date

2011-01-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Interventions

MatatacoroTM of stable chlorine dioxide ((Na)ClO2) 30 sec. at once, twice a day, 1 week, a 30 ml dose, continious 4 weeks For MatatacoroTM, an initial dose level is set at 10 ppm, and 3 patients are

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with periodontitis who was treated first

Exclusion criteria

Exclusion criteria: heavy general disease

Design outcomes

Primary

Measure	Time frame
VAS-score, Plobing pocket depth, Plobing pocket bleeding, Mean gingival Index and Mean BANA-score	—

Secondary

Measure	Time frame
2 and 4 weeks after first treatment	—

Countries

Japan

Contacts

Public ContactKimio Uchiyama

National Hospital Organization Tochigi Medical Center Department of dentistry and oral surgery

k.uchiyama@tochigi-mc.jp028-622-5241

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026